Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Mirum Pharmaceuticals Inc (MIRM) under the Base Case is 63.32 USD per share.
Compared with the current market price of 94.61 USD, the stock appears
Overvalued by 33% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Mirum Pharmaceuticals Does
Mirum Pharmaceuticals makes prescription medicines for rare liver and metabolic diseases. Its main products are branded therapies for patients with serious genetic disorders, especially children and adults who live with cholestatic liver conditions and other uncommon diseases that have few treatment options. The company sells these medicines through the healthcare system, working with specialist doctors, hospitals, and specialty pharmacies.
- Headquarters
- United States of America US
- Employees
- 369
- IPO date
- Jul 18, 2019
Revenue & Expenses Breakdown
Mirum Pharmaceuticals Inc
Earnings Waterfall
Mirum Pharmaceuticals Inc
What is the Intrinsic Value of one MIRM stock?
The intrinsic value for Mirum Pharmaceuticals Inc (MIRM) under the Base Case is 63.32 USD.
Is MIRM stock undervalued or overvalued?
Compared with the current market price of 94.61 USD, the stock appears Overvalued by 33% .
